Akebia Therapeutics, Inc.
Developing and commercializing novel, FDA-approved therapeutics for kidney disease.
AKBA | NDAQ
Overview
Corporate Details
- ISIN(s):
- US00972D1054
- LEI:
- Country:
- United States of America
- Address:
- 245 FIRST STREET, 2142 CAMBRIDGE
- Website:
- https://akebia.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Akebia Therapeutics, Inc. is a fully integrated biopharmaceutical company dedicated to developing and commercializing novel therapeutics for patients with kidney disease. The company focuses on addressing the complications of renal conditions with the purpose of bettering the lives of those impacted. As a leader in the renal community, Akebia has successfully developed unique products, including two that have received FDA approval, and aims to advance innovative therapies that establish new standards of care.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all Akebia Therapeutics, Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Akebia Therapeutics, Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Akebia Therapeutics, Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
